Empire Co Ltd (EMP.A) Class A NPV
Sell:55.46 CADBuy:55.81 CAD
0.14 CAD
(0.25%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:55.46 CAD
Buy:55.81 CAD
Change:0.14 CAD
(0.25%)
0.14 CAD
(0.25%)Prices delayed by at least 15 minutes
Sell:55.46 CAD
Buy:55.81 CAD
Change:0.14 CAD
(0.25%)
0.14 CAD
(0.25%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 June 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 55,288 | 56.17 CAD | 3,105,482.73 CAD | 166,425 |
| 24 June 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 45,474 | 55.89 CAD | 2,541,541.86 CAD | 120,951 |
| 23 June 2025 | Sandra SandersonChief Marketing Officer | Sell Option/Award related | 6,092 | 56.00 CAD | 341,126.61 CAD | 0 |
| 23 June 2025 | Sandra SandersonChief Marketing Officer | Sell Option/Award related | 1,447 | 55.98 CAD | 81,006.00 CAD | 0 |
| 23 June 2025 | Sandra SandersonChief Marketing Officer | Sell Option/Award related | 4,250 | 55.99 CAD | 237,969.80 CAD | 0 |
| 23 June 2025 | Sandra SandersonChief Marketing Officer | Sell Option/Award related | 4,526 | 56.00 CAD | 253,456.00 CAD | 19,106 |
| 20 June 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 55,492 | 55.19 CAD | 3,062,603.48 CAD | 165,459 |
| 20 June 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 44,508 | 55.19 CAD | 2,456,396.52 CAD | 120,951 |
| 20 June 2025 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 650 | 54.98 CAD | 35,737.00 CAD | 21,350 |
| 20 June 2025 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 500 | 54.92 CAD | 27,460.00 CAD | 20,850 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 April 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 98,429 | 50.29 CAD | 4,949,983.35 CAD | 0 |
| 13 December 2024 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 99,779 | 45.20 CAD | 4,509,998.64 CAD | 0 |
| 13 December 2024 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 75,844 | 44.83 CAD | 3,400,086.52 CAD | 218,984 |
| 24 June 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 55,288 | 56.17 CAD | 3,105,482.73 CAD | 166,425 |
| 20 June 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 55,492 | 55.19 CAD | 3,062,603.48 CAD | 165,459 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.